Skip to main content
Human Vaccines & Immunotherapeutics logoLink to Human Vaccines & Immunotherapeutics
. 2021 Apr 6;17(7):2350. doi: 10.1080/21645515.2021.1907076

Correction

PMCID: PMC8189042  PMID: 33822681

Article title: Economic burden of pneumococcal infections in children under 5 years of age

Authors: Mehmet Ceyhan, Yasemin Ozsurekci, Kubra Aykac, Basak Hacibedel & Egemen Ozbilgili

JournalHuman Vaccines & Immunotherapeutics

Bibliometrics: Volume 14, Issue 1, pages 106-110

DOI10.1080/21645515.2017.1371378

This article was originally published with an incomplete conflict of interest statement. This has been updated in the online version and the statement can also be found below:

Mehmet Ceyhan received personal fees and non-financial support from Pfizer, Inc., during the conduct of the study, as well as project support from MSD and GSK, Inc., outside the submitted work. Basak Hacibedel is an employee of Pfizer, Turkey and reports personal fees during the conduct of the study and outside the submitted work. Egemen Ozbilgili is an employee of Pfizer, Turkey and reports personal fees during the conduct of the study and outside the submitted work. Yasemin Ozsurekci received non-financial support from Pfizer, Turkey. Kubra Aykac received non-financial support from Pfizer, Turkey. 


Articles from Human Vaccines & Immunotherapeutics are provided here courtesy of Taylor & Francis

RESOURCES